RUNX2 promotes the development of Blastic plasmacytoid dendritic cell neoplasm (BPDCN). RUNX2 promotes the development of Blastic plasmacytoid dendritic cell neoplasm (BPDCN)

To understand how RUNX2 promoted the development of BPDCN, we transduced RUNX2-directed shRNA vectors in a BPDCN cell line, CAL-1 and performed microarray analysis of RUNX2-knocked down CAL-1 cells Overall design: CAL-1 cells were transduced with two distinct RUNX2-directed shRNA vectors containing IRES-GFP. As RUNX2-directed shRNA-transduced cells significantly reduced levels of RUNX2 expression, compared to the control Luciferase-directed shRNA-transduced cells, we perfomed gene expression analysis of RUNX2-knocked down CAL-1 cells.